The Company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.


Updates from The Motley Fool

Latest updates on Akorn from Fool.com.


Stock Performance

AKRX vs. S&P 500 | 2 Year Performance
View Interactive AKRX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Akorn.
Current Price: $29.22
Prev Close: $27.88
Open: $27.85
Bid: $28.87
Ask: $29.87
Day's Range: $27.75 - $29.30
52wk Range: $17.57 - $39.46
Volume: 1,781,283
Avg Vol 1,162,929
Market Cap: $3.34B
P/E (ttm): 46.47
EPS (ttm): $0.60
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Akorn.
CAPS Rating 3 out of 5
 
216 Outperform
18 Underperform
CAPS All Stars
 
35 Outperform
5 Underperform

How do you think Akorn will perform against the market?



You pick for Akorn is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Raj Rai, CEO

38% Approve

Based on 16 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Akorn.

The Company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers